Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$4K Hold
500
﹤0.01% 155
2022
Q3
$4K Hold
500
﹤0.01% 153
2022
Q2
$6K Hold
500
﹤0.01% 136
2022
Q1
$7K Hold
500
﹤0.01% 130
2021
Q4
$3K Hold
500
﹤0.01% 140
2021
Q3
$4K Hold
500
﹤0.01% 127
2021
Q2
$6K Hold
500
﹤0.01% 123
2021
Q1
$6K Hold
500
﹤0.01% 124
2020
Q4
$2K Hold
500
﹤0.01% 129
2020
Q3
$2K Hold
500
﹤0.01% 130
2020
Q2
$3K Hold
500
﹤0.01% 127
2020
Q1
$2K Hold
500
﹤0.01% 130
2019
Q4
$6K Hold
500
﹤0.01% 118
2019
Q3
$7K Hold
500
0.01% 120
2019
Q2
$7K Hold
500
0.01% 125
2019
Q1
$11K Buy
+500
New +$10.8K 0.01% 116

Other funds holding EOLS

Red Cedar Capital's EOLS Position: Q4 2022 in Review

Red Cedar Capital held its Evolus (EOLS) position steady in Q4 2022 at 500 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #155.

Red Cedar Capital first reported a position in EOLS in Q1 2019 and has held it in 16 quarters since. The position peaked at $11K in Q1 2019. 120 funds tracked by Wall St. Rank hold EOLS as of Q4 2022.

  • Red Cedar Capital held 500 shares of Evolus worth $4K as of Q4 2022.
  • Red Cedar Capital left its Evolus share count unchanged in Q4 2022.
  • Evolus made up ﹤0.01% of Red Cedar Capital's portfolio in Q4 2022, its #155 holding.
  • Red Cedar Capital first reported a position in Evolus in Q1 2019 and has held it in 16 quarters since.
  • Red Cedar Capital's Evolus position peaked at $11K in Q1 2019.
  • 120 funds tracked by Wall St. Rank held Evolus as of Q4 2022.

Based on Red Cedar Capital's 13F filing for Q4 2022, filed 6 Feb 2023.